Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature.

Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature.

Item
http://www.wikidata.org/entity/Q38122347
Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazoleThe difficult management of disseminated Sporothrix brasiliensis in a patient with advanced AIDSRetrospective Comparison of Posaconazole Levels in Patients Taking the Delayed-Release Tablet versus the Oral Suspension.Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.Comparison of clinical pharmacology of voriconazole and posaconazole.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole.Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis.Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections.Successful long-term management of invasive cerebral fungal infection following liver transplantation.Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient VariabilityAntifungal prophylaxis: why, what and how?Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).Risk factors for subtherapeutic levels of posaconazole tablet.Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis.
P2860

Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature.

Item
http://www.wikidata.org/entity/Q38122347
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Posaconazole therapeutic drug ...... and review of the literature.
@en
type
label
Posaconazole therapeutic drug ...... and review of the literature.
@en
prefLabel
Posaconazole therapeutic drug ...... and review of the literature.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Posaconazole therapeutic drug ...... and review of the literature.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698